The field of clinical research is growing at an unprecedented pace in terms of data volume and complexity, ushering in an era of personalized medicine and precision diagnostics. At the heart of this transformation lie Artificial Intelligence (AI) technologies. AI holds the potential to revolutionize critical processes, from identifying potential patient cohorts and accelerating clinical data analysis to the early prediction of adverse events. However, the integration of AI into clinical research necessitates strict adherence to internationally recognized standards to safeguard patient safety and data integrity.
The “Guiding Principles of Good AI Practice” established by international authorities such as FDA and EMA, provide 10 core principles to ensure the reliability and effectiveness of AI in clinical research. These principles offer not only a technological roadmap but also an ethical and regulatory framework.
Ethical and Operational Foundations
Since human health is the foundation of clinical research, AI applications must first comply with the **1. Human-centric by Design** principle. The development and use of AI systems must align with ethical values and patient welfare. This mandates transparency and accountability in AI decision-making processes.
The **2. Risk-based Approach** requires a risk assessment based on the context of AI use in clinical research. High-risk applications (e.g., dosage recommendations) demand proportionate validation, risk mitigation, and stricter oversight mechanisms, while lower-risk applications (e.g., data entry automation) can be more flexible. All processes must be conducted in **3. Adherence to Standards**, including GxP (Good Practice Standards).
For successful AI integration, the model’s role and scope must be clearly defined. The **4. Clear Context of Use** principle specifies the AI tool’s place in the clinical process, its expected output, and its limitations. Finally, a **5. Multidisciplinary Expertise** team, combining both clinical and technical expertise throughout the AI technology’s life cycle, must continuously ensure the model’s scientific validity and clinical appropriateness.
Data Integrity and Model Life Cycle
The quality of data, the cornerstone of clinical research, is vital for the success of AI models. The **6. Data Governance and Documentation** principle mandates that data source provenance, processing steps, and analytical decisions be traceable, verifiable, and documented in compliance with GxP requirements. The privacy and protection of sensitive patient data are an integral part of this governance.
The model itself must be developed using best software engineering practices, considering interpretability, explainability, and predictive performance, in line with **7. Model Design and Development Practices**. This facilitates understanding why and how the model produces clinical outcomes.
The actual performance of the model in the clinical setting must be continuously measured through **8. Risk-based Performance Assessment**. This assessment should cover not only the model’s technical metrics but also human-AI interactions. Furthermore, AI systems are not static; the **9. Life Cycle Management** principle requires periodic monitoring and re-evaluation to address issues like data drift.
The ultimate goal of all these technical and ethical processes is to provide **10. Clear, Essential Information**. Providing clear, accessible, and contextually relevant information to both users (clinicians) and patients regarding the AI technology’s context of use, performance, limitations, and updates is critical for maintaining trust.
Figure 1: AI Integration Cycle in Clinical Research
You can access the relevant document via the link.